Knight Therapeutics Inc. (TSX: GUD)

Knight Therapeutics Revenue

Knight Therapeutics had revenue of 332.21M CAD in the twelve months ending March 31, 2024, with 6.36% growth year-over-year. Revenue in the quarter ending March 31, 2024 was 86.60M CAD with 4.85% year-over-year growth. In the year 2023, Knight Therapeutics had annual revenue of 328.20M CAD with 11.80% growth.

• Revenue (ttm): 332.21M
• Revenue Growth: +6.36%
• P/S Ratio: 1.86
• Revenue / Employee: 458,215
• Employees: 725
• Market Cap: 618.15M CAD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	328.20M	34.64M	11.80%
Dec 31, 2022	293.56M	50.09M	20.57%
Dec 31, 2021	243.48M	43.96M	22.03%
Dec 31, 2020	199.52M	152.06M	320.39%
Dec 31, 2019	47.46M	34.96M	279.69%
Dec 31, 2018	12.50M	3.87M	44.78%
Dec 31, 2017	8.63M	2.69M	45.35%
Dec 31, 2016	5.94M	4.90M	472.81%
Dec 31, 2015	1.04M	671.68K	183.86%
Dec 31, 2014	365.32K	-	-